What are the Allegations by Patients in Invokana Cases?
Invokana is a powerful SGLT2 inhibitor drug prescribed to people with Type-2 diabetes. It was approved by the FDA in 2013 and marketed heavily by Johnson & Johnson. Unfortunately, the manufacturers weren’t as diligent with their testing as they should be. They released their product into the market without warning people of serious its serious side effects. At Invokana411, we have handled several consultations with victims and are familiar with the latest updates. Here are some of the common allegations made by patients: 1. Failing to warn of risks Invokana manufacturers failed to warn people of risks of this medicine. They concealed all side effects when the drug was first launched and continue to do so after post-market reports of complications started coming in. Companies should have informed doctors and patients of unreasonably high risks like diabetic ketoacidosis, possible amputations, blood infections, kidney problems, cardiovascular problems, etc. Failur